University of Sussex

File(s) under permanent embargo

Treatment of renal calculi by lithotripsy: minimising short-term shock wave induced renal damage by using antioxidants

journal contribution
posted on 2023-06-07, 15:06 authored by Khaleel Al-Awadi, Elijah O Kehinde, Issa Loutfi, Olusegan A Mojiminiyi, Adel Al-Hunayan, Hamdy Abdul-Halim, Ahmed Al-Sarraf, Anjum MemonAnjum Memon, Matthew P Abraham
Treatment with extracorporeal shock wave lithotripsy (ESWL), the preferred method of treating kidney stones <3 cm in size, has been shown to induce silent and often self-limiting acute and chronic lesions in the kidneys and adjacent organs. We conducted a randomized clinical trial to determine whether ESWL produces ischaemia and reperfusion injury in the kidneys and whether oral administration of antioxidants reduces the degree of short-term renal injury in patients treated with ESWL. The study included 120 patients with renal stones (1–3 cm in size) treated with ESWL. The patients were divided into three groups—patients in group A (n = 39) served as a control group and were not given any antioxidants; patients in group B (n = 41) were given two capsules of antioxidants “Nature Made r” 2 h before ESWL, and 2 and 8 h after ESWL; and patients in group C (n = 40) were given two capsules of the antioxidants 2 and 8 h after ESWL. Double ‘J’ stents were inserted in patients before treatment with ESWL. Blood and urine samples were obtained from all patients just before the start of treatment with ESWL, and at 2 and 24 h and on 7th and 28th day after ESWL. Serum levels of malondialdehyde (MDA), a-tocopherol, cholesterol, albumin and ascorbic acid, and a-tocopherol/cholesterol ratio were determined. Urinary levels of albumin and ß2 microglobulin were also determined as measures of renal tubular injury. At 24 h after ESWL, patients given antioxidants (groups B + C) had significantly reduced mean serum concentration of MDA (P < 0.001); higher levels of serum ascorbic acid (P < 0.001) and serum albumin (P < 0.001); lower a-tocopherol/cholesterol ratio, lower urinary albumin and ß2 microglobulin levels compared with patients who did not receive antioxidants (group A). These findings suggest that treatment with ESWL generates free radicals through ischaemic/reperfusion injury mechanism, and that oral administration of antioxidant may protect these patients from short term renal injury caused by ESWL.


Publication status

  • Published

File Version

  • Published version


Urological Research




Springer Verlag





Page range


Department affiliated with

  • BSMS Publications

Full text available

  • No

Peer reviewed?

  • Yes

Legacy Posted Date


First Compliant Deposit (FCD) Date


Usage metrics

    University of Sussex (Publications)


    No categories selected